Table_1_ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis.docx

Table_1_ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis.docx

<p>Endocrine therapy represents the cornerstone of treatment in hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (mBC). The natural course of this disease is marked by endocrine resistance, mainly due to Estrogen Receptor 1 (ESR1) acquired mutations. The aim of this stud...

Full description

Saved in:
Bibliographic Details
Main Author: Loredana Urso (197262) (author)
Other Authors: Grazia Vernaci (5437073) (author), Jessica Carlet (10287824) (author), Marcello Lo Mele (10287827) (author), Matteo Fassan (221852) (author), Elisabetta Zulato (223476) (author), Giovanni Faggioni (42109) (author), Alice Menichetti (6806123) (author), Elisabetta Di Liso (6806129) (author), Gaia Griguolo (5042417) (author), Cristina Falci (6806120) (author), Pierfranco Conte (5437082) (author), Stefano Indraccolo (3428690) (author), Valentina Guarneri (3562331) (author), Maria Vittoria Dieci (3603572) (author)
Published: 2021
Subjects:
Cancer
Cancer Cell Biology
Cancer Diagnosis
Cancer Genetics
Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
Chemotherapy
Haematological Tumours
Molecular Targets
Radiation Therapy
Solid Tumours
Oncology and Carcinogenesis not elsewhere classified
Estrogen Receptor 1 (ESR1)
metastatic breast cancer
endocrine therapy
ctDNA
liquid biopsy
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items